141 related articles for article (PubMed ID: 26329623)
21. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
[TBL] [Abstract][Full Text] [Related]
22. Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis.
Shigemura M; Nasuhara Y; Konno S; Shimizu C; Matsuno K; Yamguchi E; Nishimura M
J Transl Med; 2012 Jul; 10():111. PubMed ID: 22650152
[TBL] [Abstract][Full Text] [Related]
23. Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinib.
Fujiwara Y; Kiura K; Toyooka S; Hotta K; Tabata M; Takigawa N; Soh J; Tanimoto Y; Kanehiro A; Kato K; Date H; Tanimoto M
Lung Cancer; 2008 Jan; 59(1):81-7. PubMed ID: 17765355
[TBL] [Abstract][Full Text] [Related]
24. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
[TBL] [Abstract][Full Text] [Related]
25. Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer.
Park HK; Yoon CS; Na YO; Lee JK; Oh HJ; Park HY; Kho BG; Kim TO; Shin HJ; Kwon YS; Oh IJ; Kim YI; Lim SC; Kim YC; Park CK
Sci Rep; 2023 Oct; 13(1):18126. PubMed ID: 37872370
[TBL] [Abstract][Full Text] [Related]
26. Changes in pulmonary tissue structure and KL-6/MUC1 expression in a newborn rat model of hyperoxia-induced bronchopulmonary dysplasia.
Zhu Y; Fu J; You K; Jin L; Wang M; Lu D; Xue X
Exp Lung Res; 2013 Dec; 39(10):417-26. PubMed ID: 24298937
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of CA15-3, KL-6 and BCA225 are positively correlated with each other in the general population.
Ri G; Ohno S; Yamamoto T; Ito E; Furutani M; Furutani Y; Umeda Y; Tsukahara T; Hagita N; Matsuoka R
Anticancer Res; 2009 Oct; 29(10):4239-42. PubMed ID: 19846980
[TBL] [Abstract][Full Text] [Related]
28. Assessment of serum KL-6 as a prognostic marker in pulmonary tuberculosis patients.
Miwa S; Suzuki Y; Shirai M; Ohba H; Kanai M; Eifuku T; Suda T; Hayakawa H; Chida K
Int J Tuberc Lung Dis; 2013 Feb; 17(2):240-2. PubMed ID: 23228506
[TBL] [Abstract][Full Text] [Related]
29. The Value of Biomarkers as Predictors of Outcome in Patients with Rheumatoid Arthritis-Associated Usual Interstitial Pneumonia.
Lee YS; Kim HC; Lee BY; Lee CK; Kim MY; Jang SJ; Lee HS; Moon J; Colby TV; Kim DS
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):216-223. PubMed ID: 27758986
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics classified by the serum KL-6 level in patients with organizing pneumonia.
Yamaguchi K; Tsushima K; Kurita N; Fujiwara A; Soeda S; Yamaguchi A; Sugiyama S; Togashi Y; Kono Y; Kasagi S; Setoguchi Y
Sarcoidosis Vasc Diffuse Lung Dis; 2013 Mar; 30(1):43-51. PubMed ID: 24003534
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the effect of surgical lung biopsy on serum KL-6 Levels in patients with interstitial pneumonia: surgical lung biopsy does not elevate serum KL-6 levels.
Narita J; Hasegawa T; Tsuchida M; Terada M; Takada T; Hashimoto T; Aoki T; Tsukada H; Narita I; Hayashi J; Gejyo F; Suzuki E
Intern Med; 2006; 45(9):615-9. PubMed ID: 16755092
[TBL] [Abstract][Full Text] [Related]
32. Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review.
d'Alessandro M; Bergantini L; Cameli P; Vietri L; Lanzarone N; Alonzi V; Pieroni M; M Refini R; Sestini P; Bonella F; Bargagli E
Biomark Med; 2020 Jun; 14(8):665-674. PubMed ID: 32613855
[No Abstract] [Full Text] [Related]
33. Serum Krebs von den Lungen-6 levels in psoriatic patients under treatment with biologics.
Iwata H; Haga N; Sugai T; Fujita Y
J Dermatol; 2021 Mar; 48(3):376-379. PubMed ID: 33146900
[TBL] [Abstract][Full Text] [Related]
34. Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.
Sato S; Kato T; Abe K; Hanaoka T; Yano Y; Kurosaki A; Yasuda M; Sekino T; Fujiwara K; Hasegawa K
Oncol Lett; 2017 Jul; 14(1):776-786. PubMed ID: 28693233
[TBL] [Abstract][Full Text] [Related]
35. KL-6 as an Immunological Biomarker Predicts the Severity, Progression, Acute Exacerbation, and Poor Outcomes of Interstitial Lung Disease: A Systematic Review and Meta-Analysis.
Zhang T; Shen P; Duan C; Gao L
Front Immunol; 2021; 12():745233. PubMed ID: 34956179
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019.
Chen H; Qin R; Huang Z; Luo W; Zheng P; Huang H; Hu H; Wang H; Sun B
Cytokine; 2021 Dec; 148():155513. PubMed ID: 34507246
[TBL] [Abstract][Full Text] [Related]
37. Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19 Lung Injury: A Systematic Review and Meta-Analysis.
Pramana Witarto A; Samarta Witarto B; Er Putra AJ; Pramudito SL; Rosyid AN
Iran Biomed J; 2021 Nov; 25(6):381-9. PubMed ID: 34641641
[TBL] [Abstract][Full Text] [Related]
38. Elevation of serum KL-6 glycoprotein or surfactant protein-D in adult T-cell leukemia with distinct pulmonary complications.
Osaka A; Yanagihara K; Yamada Y; Hasegawa H; Inokuchi N; Hayashi T; Komoda M; Nakamura S; Aoyama M; Sawada T; Kamihira S
Tohoku J Exp Med; 2009 Jun; 218(2):99-105. PubMed ID: 19478465
[TBL] [Abstract][Full Text] [Related]
39. Serum KL-6 levels in lung cancer patients with or without interstitial lung disease.
Miyazaki K; Kurishima K; Kagohashi K; Kawaguchi M; Ishikawa H; Satoh H; Hizawa N
J Clin Lab Anal; 2010; 24(5):295-9. PubMed ID: 20872562
[TBL] [Abstract][Full Text] [Related]
40. Krebs von den Lungen-6, a promising marker in evaluating the severity of interstitial lung disease in Egyptian rheumatoid arthritis patients.
Hammoda RM; Salah-ElDin H; El-Gharbawy NH; Ragab D
Egypt J Immunol; 2021 Oct; 28(4):241-249. PubMed ID: 34882373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
